265 related articles for article (PubMed ID: 31534541)
1. Increasing the low lipid phosphate phosphatase 1 activity in breast cancer cells decreases transcription by AP-1 and expressions of matrix metalloproteinases and cyclin D1/D3.
Tang X; McMullen TPW; Brindley DN
Theranostics; 2019; 9(21):6129-6142. PubMed ID: 31534541
[TBL] [Abstract][Full Text] [Related]
2. Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins.
Chen CS; Lee CH; Hsieh CD; Ho CT; Pan MH; Huang CS; Tu SH; Wang YJ; Chen LC; Chang YJ; Wei PL; Yang YY; Wu CH; Ho YS
Breast Cancer Res Treat; 2011 Jan; 125(1):73-87. PubMed ID: 20229177
[TBL] [Abstract][Full Text] [Related]
3. Lipid phosphate phosphatase-1 expression in cancer cells attenuates tumor growth and metastasis in mice.
Tang X; Benesch MG; Dewald J; Zhao YY; Patwardhan N; Santos WL; Curtis JM; McMullen TP; Brindley DN
J Lipid Res; 2014 Nov; 55(11):2389-400. PubMed ID: 25210149
[TBL] [Abstract][Full Text] [Related]
4. Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1).
Endres M; Kneitz S; Orth MF; Perera RK; Zernecke A; Butt E
Oncotarget; 2016 Sep; 7(39):64244-64259. PubMed ID: 27588391
[TBL] [Abstract][Full Text] [Related]
5. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of matrix metalloproteinases mediates thromboxane A2-induced invasion in lung cancer cells.
Li X; Tai HH
Curr Cancer Drug Targets; 2012 Jul; 12(6):703-15. PubMed ID: 22515524
[TBL] [Abstract][Full Text] [Related]
7. δEF1 promotes osteolytic metastasis of MDA-MB-231 breast cancer cells by regulating MMP-1 expression.
Hu F; Wang C; Guo S; Sun W; Mi D; Gao Y; Zhang J; Zhu T; Yang S
Biochim Biophys Acta; 2011 Mar; 1809(3):200-10. PubMed ID: 21241837
[TBL] [Abstract][Full Text] [Related]
8. Brucine suppresses breast cancer metastasis via inhibiting epithelial mesenchymal transition and matrix metalloproteinases expressions.
Li M; Li P; Zhang M; Ma F
Chin J Integr Med; 2018 Jan; 24(1):40-46. PubMed ID: 28795388
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D3 compensates for the loss of cyclin D1 during ErbB2-induced mammary tumor initiation and progression.
Zhang Q; Sakamoto K; Liu C; Triplett AA; Lin WC; Rui H; Wagner KU
Cancer Res; 2011 Dec; 71(24):7513-24. PubMed ID: 22037875
[TBL] [Abstract][Full Text] [Related]
10. cFos is critical for MCF-7 breast cancer cell growth.
Lu C; Shen Q; DuPré E; Kim H; Hilsenbeck S; Brown PH
Oncogene; 2005 Sep; 24(43):6516-24. PubMed ID: 16027729
[TBL] [Abstract][Full Text] [Related]
11. Cobalt chloride-induced hypoxia modulates the invasive potential and matrix metalloproteinases of primary and metastatic breast cancer cells.
Fu OY; Hou MF; Yang SF; Huang SC; Lee WY
Anticancer Res; 2009 Aug; 29(8):3131-8. PubMed ID: 19661326
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
[TBL] [Abstract][Full Text] [Related]
13. Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro.
Balduyck M; Zerimech F; Gouyer V; Lemaire R; Hemon B; Grard G; Thiebaut C; Lemaire V; Dacquembronne E; Duhem T; Lebrun A; Dejonghe MJ; Huet G
Clin Exp Metastasis; 2000; 18(2):171-8. PubMed ID: 11235993
[TBL] [Abstract][Full Text] [Related]
14. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
[TBL] [Abstract][Full Text] [Related]
15. The functional role of Notch signaling in HPV-mediated transformation is dose-dependent and linked to AP-1 alterations.
Henken FE; De-Castro Arce J; Rösl F; Bosch L; Meijer CJ; Snijders PJ; Steenbergen RD
Cell Oncol (Dordr); 2012 Apr; 35(2):77-84. PubMed ID: 22271085
[TBL] [Abstract][Full Text] [Related]
16. Lipid phosphate phosphatase-1 regulates lysophosphatidate-induced fibroblast migration by controlling phospholipase D2-dependent phosphatidate generation.
Pilquil C; Dewald J; Cherney A; Gorshkova I; Tigyi G; English D; Natarajan V; Brindley DN
J Biol Chem; 2006 Dec; 281(50):38418-29. PubMed ID: 17057224
[TBL] [Abstract][Full Text] [Related]
17. EYA1 phosphatase function is essential to drive breast cancer cell proliferation through cyclin D1.
Wu K; Li Z; Cai S; Tian L; Chen K; Wang J; Hu J; Sun Y; Li X; Ertel A; Pestell RG
Cancer Res; 2013 Jul; 73(14):4488-99. PubMed ID: 23636126
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231.
Sen T; Dutta A; Chatterjee A
Anticancer Drugs; 2010 Jul; 21(6):632-44. PubMed ID: 20527725
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-1 is a crucial bone metastasis factor in a human breast cancer-derived highly invasive cell line.
Okuyama N; Matsumine A; Kosugi R; Wakabayashi H; Uchida A
Oncol Rep; 2008 Dec; 20(6):1497-504. PubMed ID: 19020733
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of matrix metalloproteinases in brain- and bone-seeking clones of metastatic MDA-MB-231 breast cancer cells.
Stark AM; Anuszkiewicz B; Mentlein R; Yoneda T; Mehdorn HM; Held-Feindt J
J Neurooncol; 2007 Jan; 81(1):39-48. PubMed ID: 16850107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
